Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
Journal of Peptide Science : an Official Publication of the European Peptide Society|May 10, 2008
Targeting the c-Myc coiled coil with interfering peptidesEva M Jouaux, Karin Schmidtkunz, Kristian M Müller, et al.Chemistry (Weinheim an Der Bergstrasse, Germany)|January 31, 2014
Total synthesis of (18S)- and (18R)-homolargazole by rhodium-catalyzed hydrocarboxylationChristoph Schotes, Dmytro Ostrovskyi, Johanna Senger, et al.European Journal of Medicinal Chemistry|February 3, 2023
A novel pan-selective bromodomain inhibitor for epigenetic drug designRobin Warstat, Mehrosh Pervaiz, Pierre Regenass, et al.Journal of Medicinal Chemistry|December 4, 2020
4-Acyl Pyrroles as Dual BET-BRD7/9 Bromodomain Inhibitors Address BETi Insensitive Human Cancer Cell LinesMartin Hügle, Pierre Regenass, Robin Warstat, et al.Chemmedchem|July 30, 2016
Identification of Highly Potent Protein Kinase C-Related Kinase 1 Inhibitors by Virtual Screening, Binding Free Energy Rescoring, and in vitro TestingInna Slynko, Karin Schmidtkunz, Tobias Rumpf, et al.Archiv Der Pharmazie|November 6, 2023
Design and synthesis of bioreductive prodrugs of class I histone deacetylase inhibitors and their biological evaluation in virally transfected acute myeloid leukemia cellsMohamed Abdelsalam, Mariia Zmyslia, Karin Schmidtkunz, et al.Frontiers in Oncology|May 20, 2020
Sirtuin 1 Inhibiting Thiocyanates (S1th)-A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine DeacetylasesNathalie Wössner, Zayan Alhalabi, Jessica González, et al.Data in Brief|May 10, 2016
Preparation data of the bromodomains BRD3(1), BRD3(2), BRD4(1), and BRPF1B and crystallization of BRD4(1)-inhibitor complexesMartin Hügle, Xavier Lucas, Gerhard Weitzel, et al.International Journal of Molecular Sciences|October 27, 2016
Metabolic Response to XD14 Treatment in Human Breast Cancer Cell Line MCF-7Daqiang Pan, Michel Kather, Lucas Willmann, et al.Chemmedchem|November 10, 2017
Structure-Activity Relationship of Propargylamine-Based HDAC InhibitorsMatthias Wünsch, Johanna Senger, Philipp Schultheisz, et al.Pageof 3